Sera Prognostics Inc (SERA) Stock Analysis

Sera Prognostics Inc (SERA) is a publicly traded company in the HEALTHCARE sector. It trades at $2.04, carries a market capitalization of $83.02M. This page summarizes the public market data, fundamentals, and frequently asked questions for SERA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $2.04
• Market Cap: $83.02M
• EPS: $-0.64
• 52-Week High: $4.09
• 52-Week Low: $1.37

Market Sentiment

Sera Prognostics Inc currently has a Neutral sentiment score of 0.08.

About Sera Prognostics Inc

None

GNG Research Analysis

GNG Research scores Sera Prognostics Inc (SERA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for SERA.

Frequently Asked Questions

Does SERA pay dividends?

Sera Prognostics Inc (SERA) does not currently pay a regular dividend.

What is SERA's market cap?

Sera Prognostics Inc (SERA) has a market capitalization of $83.02M with a current stock price of $2.04.